sepsi
lifethreaten
medic
condit
trigger
uncontrol
inflammatori
reaction
caus
entri
variou
microorgan
human
bloodstream
sepsi
mainli
encount
intens
care
unit
icu
due
reduc
immunolog
defens
icu
patient
approxim
million
patient
develop
sepsi
annual
industri
countri
mortal
rate
high
thu
treatment
sepsi
repres
major
unmet
medic
need
sepsi
encompass
two
phase
hyper
reactiv
hypo
reactiv
initi
inflammatori
stage
quickli
counterbalanc
antiinflammatori
respons
compromis
immun
system
lead
immunosuppress
recent
failur
clinic
trial
test
antiinflammatori
drug
treat
sepsi
attribut
immunosuppress
also
known
immunoparalysi
antiimmunosuppress
therapi
offer
novel
treatment
option
medic
commun
clinic
set
applic
colonystimul
factor
found
revers
sepsisassoci
immunosuppress
restor
monocyt
immunocompet
septic
nevertheless
difficulti
persist
differenti
inflammatori
stage
sepsi
determin
major
immunolog
pathway
underli
immunosuppress
sepsi
complement
system
strongli
activ
produc
larg
amount
one
potent
inflammatori
peptid
broad
spectrum
function
found
inhibit
neutrophil
innateimmun
function
reactiv
oxygen
speci
gener
phagocyt
abil
chemotaxi
also
observ
indirectli
involv
thymocyt
apoptosi
lead
destruct
central
immun
moreov
serv
master
switch
intracellular
ph
balanc
neutrophil
alter
neutrophil
inflamm
blockad
receptor
inhibit
develop
sepsi
markedli
improv
surviv
anim
thu
recogn
key
factor
pathogenesi
sepsi
figur
function
bind
highaffin
receptor
particular
detect
variou
organ
heart
liver
lung
kidney
septic
among
immunocyt
neutrophil
monocyt
dendrit
cell
dc
express
lymphocyt
gener
function
independ
put
default
receptor
import
role
balanc
biolog
effect
consid
function
receptor
express
lymphocyt
effect
immun
system
like
mediat
middl
man
previou
studi
found
complement
regul
affect
crosstalk
dc
cell
cecal
ligat
perfor
clp
induc
sepsi
howev
direct
role
lymphocyt
remain
unclear
neutrophil
make
major
subset
innateimmun
cell
interact
neutrophil
lead
pleiotrop
effect
includ
releas
cytokin
chemokin
well
recruit
inflammatori
cell
inappropri
activ
home
neutrophil
microvasculatur
contribut
patholog
manifest
sepsi
previous
observ
reduc
express
due
presenc
excess
associ
function
impair
neutrophil
poor
prognosi
septic
patient
henc
express
level
serv
earli
marker
predict
sever
fact
immunocyt
dc
natur
killer
cell
natur
killer
cell
nkt
found
involv
pathogenesi
sepsi
pathogen
effect
nkt
cell
mediat
enhanc
product
furthermor
overexpress
cell
sepsi
also
found
relat
henc
associ
immunocyt
complement
investig
bacteremia
import
featur
sepsi
clp
regard
standard
model
simul
complic
import
complement
activ
limit
bacteri
infect
also
appli
form
sepsi
induc
viral
fungal
infect
strong
evid
suggest
three
complement
pathway
strongli
activ
coronaviru
bird
flu
virusinduc
lung
inflamm
antibodi
shown
improv
outcom
viru
infect
owe
fast
massiv
natur
complement
injuri
believ
import
role
virusinduc
acut
lung
injuri
serv
ideal
target
treat
mani
lung
inflammatori
diseas
consid
success
eculizumab
progress
number
novel
drug
clinic
trial
great
promis
complement
therapeut
new
criteria
includ
organ
dysfunct
establish
infect
propos
diagnos
sepsi
defin
lifethreaten
organ
dysfunct
caus
dysregul
host
respons
henc
order
fulli
investig
complementmedi
immunodysfunct
sepsi
new
definit
sepsi
septic
shock
consid
patient
examin
longitudin
cohort
studi
